Citation Impact
Citing Papers
Treatment of Infection and Colonization Caused by Methicillin-Resistant Staphylococcus aureus
1991
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Do quantitative cultures of protected brush specimens modify the initial empirical therapy in ventilated patients with suspected pneumonia?
1996
Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia
1994
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
2000
Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
1999
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
2000
Vulvovaginal candidosis
2007 Standout
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis
1993
Specificity of Endotracheal Aspiration, Protected Specimen Brush, and Bronchoalveolar Lavage in Mechanically Ventilated Patients
1993
The Standardization of Bronchoscopic Techniques for Ventilator-Associated Pneumonia
1992
AIDS-Associated Cerebral Toxoplasmosis: An Update on Diagnosis and Treatment
1996
Usefulness of Microscopic Examination of Intracellular Organisms in Lavage Fluid in Ventilator-Associated Pneumonia
1994
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
A randomized, double‐blind, placebo‐controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection
2001
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Protected bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia
1996
Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
1997
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
2007
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Cryptococcal Pneumonia Complicating Pregnancy
1998
Diagnostic Fiberoptic Bronchoscopy in Patients with Community-acquired Pneumonia
1993
Treatment of Fluconazole-Refractory Oropharyngeal Candidiasis with Itraconazole Oral Solution in HIV-Positive Patients
1999
Causes of Fever and Pulmonary Densities in Patients with Clinical Manifestations of Ventilator-Associated Pneumonia
1994
Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors
1998
Effect of Coinfection with GB Virus C on Survival among Patients with HIV Infection
2001
Systemically Administered Antifungal Agents
1992
Recent Advances in the Management of Cryptococcal Meningitis in Patients with AIDS
1996
Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients
1998
Osteomyelitis
1997 Standout
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Diagnostic Efficiency of Endotracheal Aspirates with Quantitative Bacterial Cultures in Intubated Patients with Suspected Pneumonia: Comparison with the Protected Specimen Brush
1993
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
1997
Clinical Significance of Borderline Quantitative Protected Brush Specimen Culture Results
1993
Reappraisal of Distal Diagnostic Testing in the Diagnosis of ICU-Acquired Pneumonia
1995
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
1992
<![CDATA[<B>Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients</B>]]>
2001
Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush
1988
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Nosocomial Bronchopneumonia in the Critically III: Histologic and Bacteriologic Aspects
1992
The Treatment of Cerebrospinal Fluid Shunt Infections
2001
Antiretroviral Therapy for HIV Infection
1998
The Standardization of Criteria for Processing and Interpreting Laboratory Specimens in Patients With Suspected Ventilator-Associated Pneumonia
1992
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
1996
Iron status and the outcome of HIV infection: an overview
2001
Patient Selection for Clinical Investigation of Ventilator-Associated Pneumonia
1992
Nosocomial Pneumonia in Patients Receiving Continuous Mechanical Ventilation: Prospective Analysis of 52 Episodes with Use of a Protected Specimen Brush and Quantitative Culture Techniques
1989
Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard.
1995
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Diagnostic Fiberoptic Bronchoscopy and Protected Brush Culture in Patients with Community-Acquired Pneumonia
1990
Role of Flexible Bronchoscopy in Immunocompromised Patients With Lung Infiltrates
2004
Pneumonia due to Haemophilus influenzae Among Mechanically Ventilated Patients
1992
Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection
1997
Protected Specimen Brush in the Assessment of Ventilator-Associated Pneumonia
1993
Diagnosis of Ventilator-associated Pneumonia by Bacteriologic Analysis of Bronchoscopic and Nonbronchoscopic “Blind” Bronchoalveolar Lavage Fluid
1991
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Diagnosis of Pneumonia in Mechanically Ventilated Patients: Repeatability of the Protected Specimen Brush
1993
Cryptococcosis
2006
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
The Evolution ofCandidaSpecies and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)–Seropositive and At‐Risk HIV‐Seronegative Women
2001
Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons
1999
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
Users' Guides to the Medical Literature
2000 Standout
Prospective Evaluation of the Incidence of Bacteremia After Protected Specimen Brushing in ICU Patients With and Without Pneumonia
1993
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
2003
Host factors in the pathogenesis of HIV disease
1997
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
The Stomach Is Not a Source for Colonization of the Upper Respiratory Tract and Pneumonia in ICU Patients
1994
Cardiopulmonary Effects of Bronchoalveolar Lavage in Critically III Patients
1993
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Follow-up Protected Specimen Brushes to Assess Treatment in Nosocomial Pneumonia
1993
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Usefulness of Quantitative Cultures of BAL Fluid for Diagnosing Nosocomial Pneumonia in Ventilated Patients
1997
Malignant Gliomas in Adults
2008 Standout
"Blind" protected specimen brushing <I>versus</I> bronchoscopic techniques in the aetiolological diagnosis of ventilator-associated pneumonia
1996
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected Patients
1997
The Future of Antifungal Therapy
1996
Prospective Study of Nosocomial Pneumonia and of Patient and Circuit Colonization During Mechanical Ventilation with Circuit Changes Every 48 Hours Versus No Change
1991
The microbiome of the lung
2012
Using Bronchoalveolar Lavage to Distinguish Nosocomial Pneumonia from Systemic Inflammatory Response Syndrome
1995
Nosocomial Respiratory Tract Infections in Multiple Trauma Patients
1992
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Comparison of nonbronchoscopic bronchoalveolar lavage to open lung biopsy for the bacteriologic diagnosis of pulmonary infections in mechanically ventilated patients
1989
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates
1990
Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis
1995
Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments
1998
Is Protected Specimen Brush a Reproducible Method to Diagnose ICU-Acquired Pneumonia
1993
Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
1995
Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection
1993
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
Comparison of Tracheal Aspirates and Protected Brush Catheter Specimens for Identifying Pathogenic Bacteria in Mechanically Ventilated Patients
1989
The Role of Bronchoalveolar Lavage in Diagnosing Nonopportunistic Bacterial Pneumonia
1991
Role of Azoles in Antifungal Therapy
1996
Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: A meta-analysis
1999
Methodology for Clinical Investigation of Ventilator-Associated Pneumonia
1992
Diagnosis of nosocomial pneumonia in mechanically ventilated patients by the blind protected telescoping catheter
1993
Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia.
1994
Toxoplasma gondii: from animals to humans
2000 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Detection of Mycobacterium tuberculosis in bronchoalveolar lavage from patients with sputum smear‐negative pulmonary tuberculosis using a polymerase chain reaction assay
1998
Pulmonary Cryptococcosis: Localized and Disseminated Infections in 27 Patients with AIDS
1995
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
1998
Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD
2011
INVASIVE DIAGNOSTIC TECHNIQUES FOR PNEUMONIA: PROTECTED SPECIMEN BRUSH, BRONCHOALVEOLAR LAVAGE, AND LUNG BIOPSY METHODS
1998
Reporting the study populations of clinical trials
2000
Infection in Solid-Organ Transplant Recipients
2007 Standout
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
1997
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Amphotericin B: 30 Years of Clinical Experience
1990
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Guidelines for the management of adult lower respiratory tract infections
2005
FUNGAL INFECTIONS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
1997
Treatment of Infections Associated with Surgical Implants
2004 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Decision Making in Nosocomial Pneumonia
1995
Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS
1995
The Effect of Antibiotic Therapy on Recovery of Intracellular Bacteria From Bronchoalveolar Lavage in Suspected Ventilator-Associated Nosocomial Pneumonia
1993
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
1999
Treatment of cerebrospinal fluid shunt infections: a decision analysis
2002
Anemia of Chronic Disease
2005 Standout
Comparison of Four Methods for Assessing Airway Bacteriology in Intubated, Mechanically Ventilated Patients
1992
Guideline for Prevention of Nosocomial Pneumonia
1994
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
2002
Fluconazole
1995
Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy
2003
Quantitative cultures of protected brush specimens and bronchoalveolar lavage in ventilated patients without suspected pneumonia.
1994
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
Implementation of Bronchoscopic Techniques in the Diagnosis of Ventilator-associated Pneumonia to Reduce Antibiotic Use
1997
Diagnosis of Nosocomial Pneumonia in Mechanically Ventilated Patients
1998
Epidemiology of Ventilator-acquired Pneumonia Based on Protected Bronchoscopic Sampling
1998
Ventilator-associated Pneumonia
2002 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Pneumonia in Acute Respiratory Distress Syndrome
1998
HIV-1 Tat protein mimicry of chemokines
1998
Empiric Treatments Impair the Diagnostic Yield of BAL in HIV-Positive Patients
1997
Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines
2007
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Failure of Ketoconazole in Cryptococcal Meningitis
1982
Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm
1998
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus
1994
Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology
1997
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Bronchoscopic diagnosis of pneumonia
1994
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Invasive Candidiasis
2015 Standout
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
1996
Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications
2002
Cultivation of Nocardia spp. on chemically defined media for selective recovery of isolates from clinical specimens
1990
A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis
1979
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
1999 StandoutScience
The Crisis in Antibiotic Resistance
1992 StandoutScience
Diagnostic value of the blind brush in mechanically ventilated patients with nosocomial pneumonia
1992
Prevention of Infection Due toPneumocystis carinii
1998
Methicillin-resistant staphylococci
1988
MICROBIOLOGIC DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA
1993
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis
1987
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Antifungal agents in neonatal systemic candidiasis
1995
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Differential Lobe Lavage for Diagnosis of Acute Pneumocystis carinii Pneumonia in Patients Receiving Prophylactic Aerosolized Pentamidine Therapy
1993
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity
1999
Guidelines for Treatment of Candidiasis
2004 Standout
Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy
1985
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
1995 Standout
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells
1998 StandoutNobel
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Sepsis Syndrome, the Adult Respiratory Distress Syndrome, and Nosocomial Pneumonia
1990
Works of Peter T. Frame being referenced
Macrophages from Human Immunodeficiency Virus-Positive Persons Are Defective in Host Defense against Histoplasma Capsulatum
1995
Bronchoscopy with Bronchoalveolar Lavage in Tuberculosis and Fungal Infections
1991
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients
1994
Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection
2000
Histoplasma capsulation polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome
1989
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Detection of Cryptococcal Antigen in Bronchoalveolar Lavage Fluid: A Prospective Study of Diagnostic Utility
1992
Role of CD40 Ligand Signaling in Defective Type 1 Cytokine Response in Human Immunodeficiency Virus Infection
2001
Serum chemokine levels in patients with non-progressing HIV infection
1996
A Randomized Trial of Interferon alpha Therapy for HIV Type 1 Infection
2000
Increased Pneumocystis carinii Recovery From the Upper Lobes in Pneumocystis Pneumonia
1993
Infection of Bone byMycobacterium fortuitum Masquerading as Nocardia asteroides
1981
Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity
1994
Semiquantitative technique for estimating Pneumocystis carinii burden in the lung
1990
A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
1992
Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy
1984
The use of an indirect fluorescent antibody test for detecting Pneumocystis carinii.
1989
Bone Marrow Toxicity Associated with 5-Fluorocytosine Therapy
1977
Use of the Protected Specimen Brush in Patients with Endotracheal or Tracheostomy Tubes
1987
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections
1987
Bronchoalveolar Lavage for Diagnosing Acute Bacterial Pneumonia
1987